Importance The 340B Drug Pricing Program requires manufacturers to offer discounted drug
prices to support safety net hospitals and clinics (covered entities) providing care to low …

Antiretroviral pre-exposure prophylaxis (PrEP) is protective against HIV. Low utilization rates
amongst HIV vulnerable populations are due in part to the high cost of PrEP. Generic PrEP …

Importance Increasing demand for cancer care may be outpacing the capacity of hospitals to
provide timely treatment, particularly at referral centers such as National Cancer Institute …

Objective: To evaluate whether hospital entry into the 340B Drug Pricing Program-which
entitles eligible hospitals to discounts on drug purchases and intends for hospitals to use …

Little is known about how Medicaid disproportionate share hospital payments, which are
intended to support hospitals that serve low-income patients, are allocated or whether …

I study the impact of expanding the 340B Drug Pricing Program to include Critical Access
Hospitals (CAH) on Medicare Part B drug utilization and spending. The 340B program …

Despite consensus recommendations from the American College of Emergency Physicians
(ACEP), the Centers for Disease Control and Prevention, and the surgeon general to …

Rural-urban cancer disparities, including greater mortality rates, are partially attributable to
the limited availability of oncology services in rural communities. Without these services …

Importance Safety-net hospitals (SNHs) operate under limited financial resources and have
had challenges providing high-quality care. Medicaid expansion under the Affordable Care …

Importance The US 340B Drug Pricing Program enables eligible hospitals to receive
substantial discounts on outpatient drugs to improve hospitals' financial sustainability and …